Page last updated: 2024-08-24

norharman and Disease Models, Animal

norharman has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Hawkey, AB; Hoeng, J; Koshibu, K; Levin, ED; Peitsch, MC1
Kim, YG; Lee, J; Lee, JH; Shim, SH1
Barrot, M; Faivre, F; Majchrzak, M; Massotte, D; Muller, MA; Sánchez-Catalán, MJ; Yalcin, I1
Brittebo, EB; Fredriksson, A; Ostergren, A1
Burnham, WM; Mingo, NS1

Other Studies

5 other study(ies) available for norharman and Disease Models, Animal

ArticleYear
Subchronic effects of plant alkaloids on anxiety-like behavior in zebrafish.
    Pharmacology, biochemistry, and behavior, 2021, Volume: 207

    Topics: Alkaloids; Anabasine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Buspirone; Carbolines; Cotinine; Disease Models, Animal; Female; Harmine; Humans; Male; Nicotine; Pyridines; Solanaceae; Zebrafish

2021
Antibiofilm activities of norharmane and its derivatives against Escherichia coli O157:H7 and other bacteria.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2017, Dec-01, Volume: 36

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Carbolines; Disease Models, Animal; Drug Evaluation, Preclinical; Escherichia coli Infections; Escherichia coli O157; Klebsiella oxytoca; Pseudomonas aeruginosa

2017
Response of the Tail of the Ventral Tegmental Area to Aversive Stimuli.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017, Volume: 42, Issue:3

    Topics: Animals; Antimanic Agents; Behavior, Animal; Carbolines; Conditioning, Classical; Disease Models, Animal; Lipopolysaccharides; Lithium Chloride; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Neuralgia; Neurotoxins; Olfactory Perception; Pain; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Ventral Tegmental Area

2017
Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra.
    Journal of neural transmission (Vienna, Austria : 1996), 2006, Volume: 113, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Carbolines; Caspase 3; Caspases; Disease Models, Animal; Fluoresceins; Gait Disorders, Neurologic; Glial Fibrillary Acidic Protein; Gliosis; Harmine; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mitochondria; Motor Activity; Nerve Degeneration; Neuroglia; Neurons; Neurotoxins; Organic Chemicals; Parkinsonian Disorders; PC12 Cells; Rats; Substantia Nigra

2006
Secondary generalization in non-kindled rats following acute administration of GABA-complex and adenosine antagonists.
    Electroencephalography and clinical neurophysiology, 1990, Volume: 75, Issue:5

    Topics: Adenosine; Aminophylline; Amygdala; Animals; Bicuculline; Carbolines; Cerebral Cortex; Disease Models, Animal; Electrodes, Implanted; Epilepsies, Partial; GABA Antagonists; Harmine; Kindling, Neurologic; Male; Picrotoxin; Rats

1990